Abstract Purpose of Review Hereditary angioedema (HAE) is a disorder affecting bradykinin
regulation presenting as recurrent cutaneous or mucosal swelling. Treatment options …

Background Hereditary angioedema (HAE) is a life-long disease that often manifests by
puberty. Treatment of attacks is essential to improve quality of life and to decrease morbidity …

Purpose Hereditary angioedema (HAE) is a rare disease caused by a C1 inhibitor (C1-INH)
deficit. Clinically, HAE is manifested by repeated episodes of localized subcutaneous or …

Consensus guidelines recommend plasma-derived C1 inhibitor (C1-INH) as first-line
treatment in pregnant women with hereditary angioedema (HAE). We conducted a …

ABSTRACT Introduction Hereditary Angioedema (HAE) attacks show an increased
frequency and severity for pregnant and lactating females secondary to the hormonal …

Background Hereditary angioedema (HAE) is a rare disease characterized with recurrent
swelling of subcutaneous or mucosal tissue that resolves in approximately 3 days. It can be …

METHODS: HAE symptoms (mainly cutaneous and abdominal manifestations) were
documented in 3 previous generations on the maternal side of the family. The patient was …

Hereditary angioedema resulting from C1‐inhibitor deficiency (C1‐INH‐HAE) is a rare,
autosomal dominant disorder, characterized by recurrent attacks of edema formation. The …

Acute treatment of hereditary angioedema due to C1 inhibitor deficiency has become
available in the last 10 years and has greatly improved patients' quality of life. Two plasma …

OBJECTIVE: The course of hereditary angioedema (HAE) and the efficacy and safety of
human C1-INH concentrate were appraised during pregnancy and the postpartum period, in …